The potential of sestrins as therapeutic targets for diabetes

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Sestrins (Sesn1/2/3) belong to a small protein family that has versatile biological functions. In addition to initially characterized oxidoreductase activity, sestrins also have oxidoreductase-independent functions, including activation of AMP-activated protein kinase, inhibition of the mechanistic target of rapamycin complex 1 (mTORC1) and activation of mTORC2. As these kinases are important for metabolic regulation, sestrins have a favorable profile as potential therapeutic targets for metabolic diseases such as diabetes. Recent data are in line with such a notion. In this editorial, I have attempted to provide a brief update on the major findings in regard to sestrins in metabolism.

Original languageEnglish
Pages (from-to)1011-1015
Number of pages5
JournalExpert Opinion on Therapeutic Targets
Volume19
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Medical problems
Oxidoreductases
Chemical activation
AMP-Activated Protein Kinases
Metabolic Diseases
Metabolism
Phosphotransferases
Therapeutics
Proteins
mechanistic target of rapamycin complex 1
TOR complex 2

Keywords

  • Mechanistic target of rapamycin complex 1
  • mechanistic target of rapamycin complex 2
  • sestrin
  • v-akt murine thymoma viral oncogene homolog

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

The potential of sestrins as therapeutic targets for diabetes. / Dong, X.

In: Expert Opinion on Therapeutic Targets, Vol. 19, No. 8, 01.08.2015, p. 1011-1015.

Research output: Contribution to journalArticle

@article{b37eb704f82e4a3195b26b415f09654a,
title = "The potential of sestrins as therapeutic targets for diabetes",
abstract = "Sestrins (Sesn1/2/3) belong to a small protein family that has versatile biological functions. In addition to initially characterized oxidoreductase activity, sestrins also have oxidoreductase-independent functions, including activation of AMP-activated protein kinase, inhibition of the mechanistic target of rapamycin complex 1 (mTORC1) and activation of mTORC2. As these kinases are important for metabolic regulation, sestrins have a favorable profile as potential therapeutic targets for metabolic diseases such as diabetes. Recent data are in line with such a notion. In this editorial, I have attempted to provide a brief update on the major findings in regard to sestrins in metabolism.",
keywords = "Mechanistic target of rapamycin complex 1, mechanistic target of rapamycin complex 2, sestrin, v-akt murine thymoma viral oncogene homolog",
author = "X. Dong",
year = "2015",
month = "8",
day = "1",
doi = "10.1517/14728222.2015.1044976",
language = "English",
volume = "19",
pages = "1011--1015",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - The potential of sestrins as therapeutic targets for diabetes

AU - Dong, X.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Sestrins (Sesn1/2/3) belong to a small protein family that has versatile biological functions. In addition to initially characterized oxidoreductase activity, sestrins also have oxidoreductase-independent functions, including activation of AMP-activated protein kinase, inhibition of the mechanistic target of rapamycin complex 1 (mTORC1) and activation of mTORC2. As these kinases are important for metabolic regulation, sestrins have a favorable profile as potential therapeutic targets for metabolic diseases such as diabetes. Recent data are in line with such a notion. In this editorial, I have attempted to provide a brief update on the major findings in regard to sestrins in metabolism.

AB - Sestrins (Sesn1/2/3) belong to a small protein family that has versatile biological functions. In addition to initially characterized oxidoreductase activity, sestrins also have oxidoreductase-independent functions, including activation of AMP-activated protein kinase, inhibition of the mechanistic target of rapamycin complex 1 (mTORC1) and activation of mTORC2. As these kinases are important for metabolic regulation, sestrins have a favorable profile as potential therapeutic targets for metabolic diseases such as diabetes. Recent data are in line with such a notion. In this editorial, I have attempted to provide a brief update on the major findings in regard to sestrins in metabolism.

KW - Mechanistic target of rapamycin complex 1

KW - mechanistic target of rapamycin complex 2

KW - sestrin

KW - v-akt murine thymoma viral oncogene homolog

UR - http://www.scopus.com/inward/record.url?scp=84937138076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937138076&partnerID=8YFLogxK

U2 - 10.1517/14728222.2015.1044976

DO - 10.1517/14728222.2015.1044976

M3 - Article

VL - 19

SP - 1011

EP - 1015

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 8

ER -